OctoPlus Signs Service Contract With Axentis Pharma AG
9/14/2009 11:15:16 AM
More...
|
Axentis Pharma AG's Cystic Fibrosis Liposomal Tobramycin Receives Second Orphan Drug Designation Within Weeks
7/16/2009 6:52:49 AM
More...
|
Orphan Drug Designation for Innovative Treatment Against Lung Infections by Axentis Pharma AG
4/30/2009 12:17:30 PM
More...
|
Cystic Fibrosis Axentis Pharma AG Initiates Clinical Trial for Lung Infections
9/4/2008 9:00:16 AM
More...
|
Axentis Pharma AG Takes Over Patents and Continues Development of Innovative Platform Technology
6/26/2008 7:53:20 AM
More...
|
Axentis Pharma AG Cystic Fibrosis License Agreement Boosts Development of Therapy Against Lung Infections
12/19/2007 8:19:03 AM
More...
|